...

Target: ... Composite Score: 0.680 Price: $0.65▲33.6% Citation Quality: Pending neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
🔴 Alzheimer's Disease 🔥 Neuroinflammation 🟡 ALS / Motor Neuron Disease 🧠 Neurodegeneration
🏆 ChallengeSolve: Mitochondrial transfer between astrocytes and neurons$209K bounty →
⚠ Thin Description Senate Quality Gates →
Evidence Strength Pending (0%)
23
Citations
3
Debates
3
Supporting
2
Opposing
Quality Report Card click to collapse
B
Composite: 0.680
Top 27% of 1512 hypotheses
T1 Established
Multi-source converged and validated
T0 Axiom requires manual override only
A Mech. Plausibility 15% 0.80 Top 17%
B+ Evidence Strength 15% 0.70 Top 25%
A+ Novelty 12% 0.90 Top 16%
B Feasibility 12% 0.60 Top 47%
A Impact 12% 0.80 Top 25%
C+ Druggability 10% 0.50 Top 60%
B+ Safety Profile 8% 0.70 Top 23%
C Competition 6% 0.40 Top 92%
A Data Availability 5% 0.80 Top 18%
B Reproducibility 5% 0.60 Top 44%
Evidence
3 supporting | 2 opposing
Citation quality: 100%
Debates
1 session C+
Avg quality: 0.56
Convergence
1.00 A+ 30 related hypothesis share this target

From Analysis:

Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability

What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produce hypotheses about aging-neurodegeneration mechanisms.

→ View full analysis & debate transcript

Description

...

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["Aging Brain"]
    B["PRC2/EZH2 Decline"]
    C["H3K27me3 Loss at C4b Promoter"]
    D["NF-kappaB Activation"]
    E["IFN-gamma from Microglia"]
    F["C4b Transcription Upregulated"]
    G["C4b Protein on Synapses"]
    H["C3 Convertase Formation"]
    I["C3b Opsonization"]
    J["Microglial Phagocytosis"]
    K["Synaptic Loss in CA1"]
    L["CD46/CD55/CD59 Decline"]
    M["Cognitive Decline"]

    A -->|"epigenetic changes"| B
    B -->|"de-repression"| C
    C -->|"promotes"| F
    A -->|"inflammaging"| D
    D -->|"activates"| F
    A -->|"microglial aging"| E
    E -->|"JAK/STAT1"| F
    F -->|"cleaved C4b"| G
    G -->|"recruits C2"| H
    H -->|"amplifies"| I
    I -->|"tags synapses"| J
    J -->|"eliminates"| K
    A -->|"regulatory decline"| L
    L -->|"removes brakes"| G
    K -->|"drives"| M

    style A fill:#ffd54f,color:#000
    style F fill:#ef5350,color:#fff
    style K fill:#ef5350,color:#fff
    style M fill:#ef5350,color:#fff
    style L fill:#ce93d8,color:#000

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.80 (15%) Evidence 0.70 (15%) Novelty 0.90 (12%) Feasibility 0.60 (12%) Impact 0.80 (12%) Druggability 0.50 (10%) Safety 0.70 (8%) Competition 0.40 (6%) Data Avail. 0.80 (5%) Reproducible 0.60 (5%) KG Connect 0.59 (8%) 0.680 composite
5 citations 5 with PMID Validation: 100% 3 supporting / 2 opposing
For (3)
No supporting evidence
No opposing evidence
(2) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
2
2
1
MECH 2CLIN 2GENE 1EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
...SupportingMECH----PMID:12345678-
Neurodegeneration and Inflammation-An Interesting …SupportingCLINInt J Mol Sci-2020-PMID:33182554-
CD38 in Neurodegeneration and Neuroinflammation.SupportingGENECells-2020-PMID:32085567-
...OpposingMECH----PMID:87654321-
Mediterranean diet adherence, gut microbiota, and …OpposingCLINJ Neurol Sci-2022-PMID:35144237-
Legacy Card View — expandable citation cards

Supporting Evidence 3

Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disease.
Int J Mol Sci · 2020 · PMID:33182554
CD38 in Neurodegeneration and Neuroinflammation.
Cells · 2020 · PMID:32085567

Opposing Evidence 2

Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review…
Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review.
J Neurol Sci · 2022 · PMID:35144237
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-02 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

[MAX TOOL ROUNDS REACHED]

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

I'd be happy to critically evaluate hypotheses, but I don't see any specific hypotheses provided in your message. You mentioned "these hypotheses from the Theorist" but the actual hypotheses aren't included.

Could you please provide the specific hypotheses you'd like me to critically evaluate? Once you share them, I'll:

  • Identify specific weaknesses in the evidence and reasoning
  • Search for counter-evidence using PubMed and cite specific studies with PMIDs
  • Propose alternative explanations and confounding factors
  • Design falsification experiments to test the hypothese
  • 🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

    I notice that you've referenced hypotheses to assess, but the actual hypotheses aren't included in your message. You mentioned "[MAX TOOL ROUNDS REACHED]" which suggests there may have been a previous conversation where hypotheses were generated, but I don't have access to that content.

    To provide you with a comprehensive practical feasibility assessment, I need you to share the specific hypotheses you'd like me to evaluate. Once you provide them, I'll conduct a thorough analysis for each hypothesis covering:

    Druggability Assessment

    • Target class and structural features
    • Binding sit

    Synthesizer Integrates perspectives and produces final ranked assessments

    I understand you want me to synthesize inputs from a Theorist, Skeptic, and Expert to produce final scored rankings of hypotheses. However, I'm missing the critical components needed for this synthesis:

  • The original hypotheses from the Theorist
  • The critique with citations from the Skeptic
  • The feasibility assessment from the Expert
  • What I see are placeholder messages indicating:

    • "HYPOTHESES: [MAX TOOL ROUNDS REACHED]"
    • The Skeptic asking for hypotheses to critique
    • The Expert asking for hypotheses to assess feasibility

    To perform the synthesis you've requested, I n

    Price History

    0.250.500.75 created: market_dynamics (2026-04-02T21:38)score_update: market_dynamics (2026-04-02T21:38)debate: market_dynamics (2026-04-02T22:13)evidence: market_dynamics (2026-04-02T23:05)score_update: market_dynamics (2026-04-02T23:06)evidence: market_dynamics (2026-04-03T00:00)evidence: evidence_batch_update (2026-04-03T01:06)evidence: evidence_batch_update (2026-04-03T01:06)debate: market_dynamics (2026-04-03T02:09)evidence: market_dynamics (2026-04-03T05:28)score_update: market_dynamics (2026-04-03T05:44)debate: market_dynamics (2026-04-03T05:59)debate: market_dynamics (2026-04-03T06:55)score_update: market_dynamics (2026-04-03T09:06)evidence: evidence_batch_update (2026-04-04T09:08)evidence: evidence_batch_update (2026-04-13T02:18)evidence: evidence_batch_update (2026-04-13T02:18) 1.00 0.00 2026-04-022026-04-132026-04-26 Market PriceScoreevidencedebate 181 events
    7d Trend
    Falling
    7d Momentum
    ▼ 7.8%
    Volatility
    Low
    0.0170
    Events (7d)
    7
    ⚡ Price Movement Log Recent 15 events
    Event Price Change Source Time
    📄 New Evidence $0.500 ▲ 2.0% evidence_batch_update 2026-04-13 02:18
    📄 New Evidence $0.490 ▲ 4.3% evidence_batch_update 2026-04-13 02:18
    Recalibrated $0.470 ▼ 1.2% 2026-04-10 15:58
    Recalibrated $0.476 ▲ 1.4% 2026-04-10 15:53
    Recalibrated $0.469 ▲ 0.3% 2026-04-08 18:39
    Recalibrated $0.468 ▼ 0.7% 2026-04-04 16:38
    Recalibrated $0.471 ▼ 1.9% 2026-04-04 16:02
    📄 New Evidence $0.481 ▲ 2.3% evidence_batch_update 2026-04-04 09:08
    Recalibrated $0.470 ▼ 26.0% 2026-04-03 23:46
    📊 Score Update $0.635 ▲ 37.4% market_dynamics 2026-04-03 09:06
    💬 Debate Round $0.462 ▲ 99.8% market_dynamics 2026-04-03 06:55
    💬 Debate Round $0.231 ▼ 53.1% market_dynamics 2026-04-03 05:59
    📊 Score Update $0.493 ▲ 15.3% market_dynamics 2026-04-03 05:44
    📄 New Evidence $0.428 ▼ 41.7% market_dynamics 2026-04-03 05:28
    💬 Debate Round $0.735 ▲ 0.8% market_dynamics 2026-04-03 02:09

    Clinical Trials (5) Relevance: 38%

    0
    Active
    0
    Completed
    1,240
    Total Enrolled
    PHASE1
    Highest Phase
    Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI NA
    UNKNOWN · NCT04887675 · University of Novi Sad
    120 enrolled · 2021-05-01 · → 2022-06-01
    Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
    HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
    MRI
    An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy Unknown
    ENROLLING_BY_INVITATION · NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
    310 enrolled · 2025-02-14 · → 2026-10-01
    The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
    Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
    Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders Unknown
    RECRUITING · NCT00029965 · National Human Genome Research Institute (NHGRI)
    200 enrolled · 2002-02-06
    Study description: This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
    Neurological Regression Myoclonus Cherry Red Spot
    Retinal and Cognitive Dysfunction in Type 2 Diabetes Unknown
    COMPLETED · NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
    510 enrolled · 2020-11-16 · → 2024-12-12
    The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
    Retinal Function Cognitive Dysfunction Microperimetry
    A Noval Tau Tracer in Young Onset Dementia PHASE1
    UNKNOWN · NCT04248270 · Chang Gung Memorial Hospital
    100 enrolled · 2020-02-20 · → 2023-08-17
    Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
    Alzheimer's Disease Vascular Dementia Dementia
    18F-PM-PBB3

    📚 Cited Papers (51)

    Adaptive learning algorithms to optimize mobile applications for behavioral health: guidelines for design decisions.
    Journal of the American Medical Informatics Association : JAMIA (2021) · PMID:33657217
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    [WALANT - Wide Awake Local Anaesthesia No Tourniquet: Complications in elective and acute traumatological Hand Surgery Procedures].
    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V... (2022) · PMID:35168268
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    Engineering complex communities by directed evolution.
    Nature ecology & evolution (2021) · PMID:33986540
    9 figures
    Extended Data Figure 1.
    Extended Data Figure 1.
    Non-additive function, costly function, and two empirically motivated functions. (A) Illustration of the different types of community function we have considered. In addition to th...
    pmc_api
    Extended Data Figure 2.
    Extended Data Figure 2.
    Alternative ecological scenarios with metabolic cross-feeding. Besides the rich medium without cross-feeding shown in the main text, we have included two other ecological scenarios...
    pmc_api
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    Denpasar Declaration on Population and Development.
    Integration (Tokyo, Japan) (1994) · PMID:12345678
    No extracted figures yet
    No extracted figures yet
    No extracted figures yet
    No extracted figures yet
    No extracted figures yet
    No extracted figures yet

    📓 Linked Notebooks (8)

    📓 SciDEX Analysis: 2026 04 02 Gap Aging Mouse Brain 20260402
    Computational notebook for SDA-2026-04-02-gap-aging-mouse-brain-20260402
    📓 Top 5 Analysis: Sda 2026 04 02 Gap Aging Mouse Brain 20260402
    Computational notebook for SDA-2026-04-02-gap-aging-mouse-brain-20260402
    📓 Aging mouse brain — Analysis Notebook
    Comprehensive analysis notebook
    📓 Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability - Top 5 Rich Notebook
    Rich notebook with gene expression, pathway enrichment, KG network, score heatmaps, and statistical analysis.
    📓 Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability — Analysis Notebook
    Jupyter notebook for analysis SDA-2026-04-02-gap-aging-mouse-brain-20260402: What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain …
    📓 Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability — Rich Analysis Notebook
    Enhanced notebook with gene expression, pathway enrichment, and statistical analysis for: What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use A
    📓 Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability — Analysis Notebook
    CI-generated notebook stub for analysis SDA-2026-04-02-gap-aging-mouse-brain-20260402. What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mo …
    📓 Gene Expression in Aging Mouse Brain Predicting Neurodegeneration (v1)
    What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Using Allen Brain Atlas aging datasets, identify conserved transcriptomic signatures across 3, 12, 18, an …
    → Browse all notebooks

    ⚔ Arena Performance

    No arena matches recorded yet. Browse Arenas
    → Browse all arenas & tournaments

    📊 Resource Economics & ROI

    Moderate Efficiency Resource Efficiency Score
    0.70
    42.0th percentile (776 hypotheses)
    Tokens Used
    9,409
    KG Edges Generated
    202
    Citations Produced
    23

    Cost Ratios

    Cost per KG Edge
    37.64 tokens
    Lower is better (baseline: 2000)
    Cost per Citation
    588.06 tokens
    Lower is better (baseline: 1000)
    Cost per Score Point
    15424.59 tokens
    Tokens / composite_score

    Score Impact

    Efficiency Boost to Composite
    +0.070
    10% weight of efficiency score
    Adjusted Composite
    0.750

    How Economics Pricing Works

    Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

    High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

    Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

    Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

    Efficiency Price Signals

    Date Signal Price Score
    2026-04-16T20:00$0.4800.510

    Wiki Pages

    ANG ProteinproteinANG — AngiogeningeneParaneoplastic Cerebellar Degeneration NeuronscellC4B GenegeneNeurodegenerationdiseaseC4B ProteinproteinC4B GenegeneAlibaba Tongyi Qianwen-Bio (Chinese Biomedical LLMai_toolASC (PYCARD)geneStrokediseasePyramidal NeuronscellCa1 Pyramidal Neuronscell_typeAlzheimer's DiseasediseaseSchizophreniadiseaseComplement Systementity

    KG Entities (2)

    ...neurodegeneration

    Related Hypotheses

    TREM2-Dependent Astrocyte-Microglia Cross-talk in Neuroinflammation
    Score: 0.000 | neurodegeneration
    Focused Ultrasound-Enhanced CYP46A1 Gene Therapy for Neurodegeneration
    Score: 0.000 | neurodegeneration
    CYP46A1 Inhibition Therapy for Neurodegeneration
    Score: 0.000 | neurodegeneration
    TREM2-Mediated Senescent Microglial Reprogramming of Astrocyte Networks
    Score: 0.000 | neurodegeneration
    TREM2-Mediated Oligodendrocyte Metabolic Support in White Matter Neurodegeneration
    Score: 0.000 | neurodegeneration

    Estimated Development

    Estimated Cost
    $0
    Timeline
    2.0 years

    🧪 Falsifiable Predictions (4)

    4 total 0 confirmed 0 falsified
    If hypothesis is true, intervention preserve complement's protective functions in pathogen defense and debris clearance
    pending conf: 0.70
    Expected outcome: preserve complement's protective functions in pathogen defense and debris clearance
    Falsified by: Intervention fails to preserve complement's protective functions in pathogen defense and debris clearance
    If hypothesis is true, intervention benefit most from complement-targeted therapy
    pending conf: 0.70
    Expected outcome: benefit most from complement-targeted therapy
    Falsified by: Intervention fails to benefit most from complement-targeted therapy
    If hypothesis is true, intervention prevent C4b generation
    pending conf: 0.70
    Expected outcome: prevent C4b generation
    Falsified by: Intervention fails to prevent C4b generation
    If hypothesis is true, intervention overcome this limitation
    pending conf: 0.70
    Expected outcome: overcome this limitation
    Falsified by: Intervention fails to overcome this limitation

    Knowledge Subgraph (1 edges)

    implicates in (1)

    ...neurodegeneration

    3D Protein Structure

    🧬 ... — Search for structure Click to search RCSB PDB
    🔍 Searching RCSB PDB for ... structures...
    Querying Protein Data Bank API

    Source Analysis

    Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability

    neurodegeneration | 2026-04-02 | completed

    Community Feedback

    0 0 upvotes · 0 downvotes
    💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

    No comments yet. Be the first to comment!

    View all feedback (JSON)